Gert Schaart
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial.
Journal: Nature communications
Published: June 18, 2025
ATGL-mediated lipolysis is essential for myocellular mitochondrial function, mitochondria-lipid droplet interaction and mitochondrial network connectivity.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: June 03, 2025
Natural daylight during office hours improves glucose control and whole-body substrate metabolism.
Journal: Cell metabolism
Published: February 23, 2025
Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular Carcinoma.
Journal: Cellular and molecular gastroenterology and hepatology
Published: November 12, 2024
Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: October 23, 2024
Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2.
Journal: Basic research in cardiology
Published: March 05, 2024
Cold acclimation with shivering improves metabolic health in adults with overweight or obesity.
Journal: Nature metabolism
Published: January 22, 2024
Twenty-four hour rhythmicity in mitochondrial network connectivity and mitochondrial respiration; a study in human skeletal muscle biopsies of young lean and older individuals with obesity.
Journal: Molecular metabolism
Published: December 21, 2022
PCr/ATP ratios and mitochondrial function in the heart. A comparative study in humans.
Journal: Scientific reports
Published: December 11, 2022
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial.
Journal: Metabolism: clinical and experimental
Published: November 01, 2022
The tissue-specific metabolic effects of the PPARα agonist ciprofibrate in insulin-resistant male individuals: a double-blind, randomized, placebo-controlled crossover study.
Journal: Obesity (Silver Spring, Md.)
Published: October 21, 2022
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism.
Journal: Molecular metabolism
Published: September 06, 2022
Last Updated: 09/26/2026